224 related articles for article (PubMed ID: 32474395)
1. Generation of induced pluripotent stem cells (KSCBi009-A) from a patient with Prader-Willi syndrome (PWS) featuring deletion of the paternal chromosome region 15q11.2-q13.
Kim BY; Lee JS; Kim YO; Koo SK; Park MH
Stem Cell Res; 2020 Jul; 46():101847. PubMed ID: 32474395
[TBL] [Abstract][Full Text] [Related]
2. Generation of patient-specific induced pluripotent stem cells (KSCBi007-A) derived from a patient with Prader-Willi syndrome retain maternal uniparental disomy (UPD).
Kim BY; Lee JS; Kim YO; Park MH; Koo SK
Stem Cell Res; 2019 Dec; 41():101647. PubMed ID: 31756696
[TBL] [Abstract][Full Text] [Related]
3. Prader-Willi syndrome and atypical submicroscopic 15q11-q13 deletions with or without imprinting defects.
Hassan M; Butler MG
Eur J Med Genet; 2016 Nov; 59(11):584-589. PubMed ID: 27659713
[TBL] [Abstract][Full Text] [Related]
4. Generation of an induced pluripotent stem cell line, ZIPi021-A, from fibroblasts of a Prader-Willi syndrome patient with maternal uniparental disomy (mUPD).
Heseding H; Jahn K; Brändl B; Haase A; Shum IO; Kohrn T; Bleich S; Frieling H; Martin U; Müller FJ; Wunderlich S; Deest M
Stem Cell Res; 2023 Sep; 71():103143. PubMed ID: 37343429
[TBL] [Abstract][Full Text] [Related]
5. Changeability of the fully methylated status of the 15q11.2 region in induced pluripotent stem cells derived from a patient with Prader-Willi syndrome.
Okuno H; Nakabayashi K; Abe K; Ando T; Sanosaka T; Kohyama J; Akamatsu W; Ohyama M; Takahashi T; Kosaki K; Okano H
Congenit Anom (Kyoto); 2017 Jul; 57(4):96-103. PubMed ID: 28004416
[TBL] [Abstract][Full Text] [Related]
6. Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome.
Henkhaus RS; Kim SJ; Kimonis VE; Gold JA; Dykens EM; Driscoll DJ; Butler MG
Genet Test Mol Biomarkers; 2012 Mar; 16(3):178-86. PubMed ID: 21977908
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of the chromosome 15q11-q13 Prader-Willi syndrome region and characterization of transcripts for GOLGA8E and WHCD1L1 from the proximal breakpoint region.
Jiang YH; Wauki K; Liu Q; Bressler J; Pan Y; Kashork CD; Shaffer LG; Beaudet AL
BMC Genomics; 2008 Jan; 9():50. PubMed ID: 18226259
[TBL] [Abstract][Full Text] [Related]
8. Generation of a transgene-free induced pluripotent stem cell line (SMBCi011-A) from a patient with Prader-Willi syndrome.
Jia G; Cui Y; Shi L; Luan J; Wang J; Han J
Stem Cell Res; 2022 Apr; 60():102695. PubMed ID: 35203049
[TBL] [Abstract][Full Text] [Related]
9. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification.
Procter M; Chou LS; Tang W; Jama M; Mao R
Clin Chem; 2006 Jul; 52(7):1276-83. PubMed ID: 16690734
[TBL] [Abstract][Full Text] [Related]
10. Clinical Utility of Methylation-Specific Multiplex Ligation-Dependent Probe Amplification for the Diagnosis of Prader-Willi Syndrome and Angelman Syndrome.
Kim B; Park Y; Cho SI; Kim MJ; Chae JH; Kim JY; Seong MW; Park SS
Ann Lab Med; 2022 Jan; 42(1):79-88. PubMed ID: 34374352
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of imprinting of the Prader-Willi/Angelman region.
Horsthemke B; Wagstaff J
Am J Med Genet A; 2008 Aug; 146A(16):2041-52. PubMed ID: 18627066
[TBL] [Abstract][Full Text] [Related]
12. Mosaicism for maternal uniparental disomy 15 in a boy with some clinical features of Prader-Willi syndrome.
Zilina O; Kahre T; Talvik I; Oiglane-Shlik E; Tillmann V; Ounap K
Eur J Med Genet; 2014; 57(6):279-83. PubMed ID: 24704109
[TBL] [Abstract][Full Text] [Related]
13. [Methylation-specific multiplex ligation-dependent probe amplification in diagnosis of Prader-Willi syndrome and Angelman syndrome].
Li MR; Wang XZ; Liu XY; Yang YL; Bao XH; Zhang YH; Xiong H; Zhong N; Qin J; Wu XR; Pan H
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3257-61. PubMed ID: 19159549
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for Prader-Willi syndrome is feasible: Early diagnosis for better outcomes.
Mahmoud R; Singh P; Weiss L; Lakatos A; Oakes M; Hossain W; Butler MG; Kimonis V
Am J Med Genet A; 2019 Jan; 179(1):29-36. PubMed ID: 30556641
[TBL] [Abstract][Full Text] [Related]
15. Unique maternal deletion of 15q in a patient with some symptoms of Prader-Willi syndrome.
Ninomiya S; Yokoyama Y; Kawakami M; Une T; Maruyama H; Morishima T
Pediatr Int; 2005 Oct; 47(5):541-5. PubMed ID: 16190961
[TBL] [Abstract][Full Text] [Related]
16. Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes.
Glenn CC; Driscoll DJ; Yang TP; Nicholls RD
Mol Hum Reprod; 1997 Apr; 3(4):321-32. PubMed ID: 9237260
[TBL] [Abstract][Full Text] [Related]
17. Prader-Willi syndrome patient with atypical phenotypes caused by mosaic deletion in the paternal 15q11-q13 region: a case report.
Wu J; Lei M; Wang X; Liu N; Xu X; Gu C; Yu Y; Liu W
Ital J Pediatr; 2022 Dec; 48(1):204. PubMed ID: 36582000
[TBL] [Abstract][Full Text] [Related]
18. Three siblings with Prader-Willi syndrome caused by imprinting center microdeletions and review.
Hartin SN; Hossain WA; Weisensel N; Butler MG
Am J Med Genet A; 2018 Apr; 176(4):886-895. PubMed ID: 29437285
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel imprinted transcripts in the Prader-Willi syndrome and Angelman syndrome deletion region: further evidence for regional imprinting control.
Lee S; Wevrick R
Am J Hum Genet; 2000 Mar; 66(3):848-58. PubMed ID: 10712201
[TBL] [Abstract][Full Text] [Related]
20. Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders.
Depienne C; Moreno-De-Luca D; Heron D; Bouteiller D; Gennetier A; Delorme R; Chaste P; Siffroi JP; Chantot-Bastaraud S; Benyahia B; Trouillard O; Nygren G; Kopp S; Johansson M; Rastam M; Burglen L; Leguern E; Verloes A; Leboyer M; Brice A; Gillberg C; Betancur C
Biol Psychiatry; 2009 Aug; 66(4):349-59. PubMed ID: 19278672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]